Patent directory · USPTO A61K / A61P
Patents matching “adenosine”
64 pharma patents match "adenosine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 64 pharmaceutical patents matching "adenosine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12378248
A1 adenosine receptor agonists and methods of use thereof
granted -
US 12325708
Adenosine 2 receptor antagonists
granted -
US 12310965
Treatment of cancer utilizing an identified adenosine fingerprint
granted -
US 12213990
A3 adenosine receptor ligand for use for achieving a fat loss effect
granted -
US 12174192
Methods for detecting and treating cancers having adenosine pathway activation
granted -
US 12168023
Inhibitors of adenosine 5′-nucleotidase
granted -
US 12116635
Methods for detecting and treating cancers having adenosine pathway activation
granted -
US 11795443
Uses of adenosine base editors
granted -
US 11591579
Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy
granted -
US 11584923
Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same
granted -
US 11471528
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
granted -
US 11396647
Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy
granted -
US 11254686
Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor
granted -
US 11246871
Targeting adenosine A2A receptors for the treatment of levodopa-induced dyskinesias
granted -
US 11155803
Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence
granted -
US 11118167
Enzyme-mediated depletion of adenosine and/or methylthioadenosine
granted -
US 11058704
Inhibitors of adenosine 5′-nucleotidase
granted -
US 11040091
Cycle adenosine monophosphate-incompetent adenylyl cyclase and compositions and methods for treating heart failure and increasing cardiac function
granted -
US 10583180
Method for treating adenosine deaminase severe combined imunodeficiency
granted -
US 10577368
A3 adenosine receptor agonists
granted -
US 10376515
Analogs of adenosine monophosphate (AMP) as inhibitors of ubiquitin-like modifier-activating enzyme ATG7
granted -
US 10314908
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
granted -
US 10265337
Use of A3 adenosine receptor agonist in osteoarthritis treatment
granted -
US 10016432
Methanocarba derivatives of pseudoribose that inhibit adenosine kinase
granted